Navigation Links
Rural Hospital Chooses Microsoft Dynamics GP for Healthy Time and Labor Savings
Date:2/14/2008

efits from Microsoft Dynamics GP:

-- Cost savings. With Microsoft Dynamics GP's automated and integrated

accounting system, the hospital expects to reduce labor costs by 30

percent.

-- Time savings. All departments in the hospital's administration hope to

realize time savings of 50 percent.

-- Improved accuracy of data. Data entered in the hospital's previous

system was only about 80 percent accurate. With Microsoft Dynamics GP,

accuracy is expected to increase to nearly 100 percent.

-- Better reporting. The automated reporting capabilities of Microsoft

Dynamics GP were a primary benefit that drove the hospital's decision

to choose this solution. Holy Infant moves from a system providing

virtually no reports or financial details to one that offers very

comprehensive and detailed reporting in an easy-to-use, integrated

fashion.

-- Improved cash flow. With invoices prepared and sent more quickly,

payments should be received more rapidly as well, leading to financial

efficiencies and better cash flow.

-- Easier budget planning. With the budgeting and forecasting features of

Microsoft Dynamics GP, its assistance in preparing timely and accurate

budgets will be immeasurable.

-- Integration of functions. Another important factor in the hospital's

selection of Microsoft Dynamics GP is its ease of integration -- with

payroll, with the Microsoft Office suite of applications in which the

hospital already had invested, and with other functions -- which will

enable Holy Infant Hospital to get up and running quickly and

cost-effectively with the new technology.

-- IT support and management. Microsoft Dynamics GP, based on the highly

reliable Microsoft SQL Server, frees up time for existing IT personnel

to support an increased range of IT
'/>"/>

SOURCE Microsoft Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Rural/Metro Announces Results for Fiscal 2008 Second Quarter
2. Rural/Metro to Host Conference Call to Discuss Fiscal 2008 Second Quarter Results
3. PA Commission for Women Announces Shocking Pink Osteoporosis Campaign in Rural PA
4. Rural Residents Get Fewer Organ Transplants: Study
5. Cardinal Health Foundation Grants $537,000 to Rural, Public Hospitals in Support of IHIS 5 Million Lives Campaign
6. Internet2 Congratulates FCC Rural Health Care Pilot Program Grant Awardees
7. Rural patients colon and lung cancers diagnosed earlier, Dartmouth research says
8. Medicare Cuts Pose Disproportionate Threat to Idahos Rural Seniors, Local Jobs Base
9. Rural/Metro Announces Results for Fiscal 2008 First Quarter; Fiscal 2007 Fourth Quarter and Full Year
10. Anti-smoking strategy targets fourth-graders, parents in rural and urban Georgia
11. Study reveals differences in cancer stage presentation between rural and urban patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)...c. (NYSE: WLP ) announced,today that senior mana...J.P.,Morgan Healthcare Conference on Jan. 12, 2009...astern Standard Time). , WellPoint, Inc. is sc...months ended Dec. 31, 2008, on January 28, 2009. W...r to this scheduled earnings release, and therefor...
(Date:1/7/2009)...ises, Inc. (BME), a cutting edge medical device co...mory metal implants, announced today that it has a...f Executive Officer. W. Casey Fox, PhD, P.E., BME...nd continue to focus his efforts on building BME,s...es in nitinol implants that contract and compress ...
(Date:1/7/2009)...the troubles of those born at 39 weeks, , ...ng an elective repeat C-section should wait until ...have the baby, if there are no medical issues with...ing just two weeks earlier doubles the risk that t...ing, infection and low blood sugar, according to t...
(Date:1/7/2009)...known as Emily,s Law, has received Governor Ted St...l in the state of Ohio. Named after Emily Jerry, E...gulations for pharmacy technicians. The law, which... was drafted with assistance of the National Pharm... Emily Jerry died at the age of two as the result ...
Breaking Medicine News(10 mins):Health News:WellPoint Announces Appearance at Upcoming Conference 2Health News:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer 2Health News:Early Elective C-Sections Produce Complications 2Health News:Early Elective C-Sections Produce Complications 3Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3
... aside promises of slimmer portions and healthy me...ze version// of the Big Mac, now to be made 40 per...sized burger, expected to contain at least 690 cal...orld Cup promotion for the summer. Vigorous advert...
...offering "bloodless surgery" to almost 90% of its ...now joins an ever-growing number of hospitals that...ne around the country. This option was once only ...is now provided in certain hospitals to more patie...
...d hence various organizations are putting in their...nizations are working towards the complete eradica...One such step is taken by the Manipur AIDS Control...al organizations (NGOs) who are thriving day and n...
...dical negligence, surgeons have reported the remov...ide the patient's abdomen three years ago//. The f...r old Pakistani patient while she had underwent ap...consisting of three senior surgeons and four param...
Other Medicine News:
(Date:1/7/2009).../ -- ImQuest Life Sciences announced today the suc...od and Drug Administration to initiate human clini...bitor IQP-0410. ImQuest anticipates initiating the...QP-0410 is a novel small molecule inhibitor of HIV...ranscriptase inhibitor (NNRTI). The compound posse...
(Date:1/6/2009)...lts from prior U.S., U.K. and China Trials , , ... Inc. (VTI), a development stage company targeting... has begun for a randomized, controlled, multi-cen...tracorporeal Liver Assist Device (ELAD) as a treat...nder three protocols. The study is open for enroll...
(Date:1/6/2009)...-USNewswire/ -- Sequella, Inc., a clinical-stage b...idemic potential, announced today that SQ109, its ...sis (TB), was the first drug approved for evaluati... Dynport Vaccine Company LLC and Quintiles Transna...itute of Allergy and Infectious Diseases (NIAID), ...
(Date:1/5/2009)...Cylene Pharmaceuticals announced today that it has...2 protein kinase inhibitor, CX-4945, in patients w... multiple myeloma. The primary endpoints of the or...ty, tolerance and PK properties of CX-4945 and to ...n addition, multiple mechanism-related pharmacodyn...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Raydiance collaborates with Rutgers MTF to develop innovative tissue processing approaches 1269 1Raydiance collaborates with Rutgers MTF to develop innovative tissue processing approaches 1269 2MU study finds that sitting may increase risk of disease 1265 1MU study finds that sitting may increase risk of disease 1265 2MU study finds that sitting may increase risk of disease 1265 3New HPV vaccine under study 6618 1New HPV vaccine under study 6618 2Stress hormone may hasten the progression of certain blood cancers 6614 1Stress hormone may hasten the progression of certain blood cancers 6614 2Stress hormone may hasten the progression of certain blood cancers 6614 3
...Kinetics Profile, LAUSANNE, Switzerland, April 19,...), a global independent biopharmaceutical,developm...ditions,presented additional results of a previou...hibitor Debio 025 in HIV/HCV (hepatitis C,virus) c...e 42nd,Annual Meeting of the European Association ...
...USINESS WIRE)--Apr 19, 2007 - Abraxis BioScience,...aceutical,company, discussed results from two pre-...erapy induced angiogenesis and,rationale for combi...spension (paclitaxel protein-bound particles for i...nhibitor drugs like,bevacizumab (Avastin(R)) at th...
Other Medicine Technology:Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 2Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 3Clinical Update - Debio 025 Cyclophilin Inhibitor for the Treatment,of HCV 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 2Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 3Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 4Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response 5
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: